Australia markets close in 5 hours 7 minutes

Outlook Therapeutics, Inc. (OTLK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.19-0.01 (-0.12%)
At close: 04:00PM EDT
8.08 -0.11 (-1.34%)
After hours: 07:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 191.05M
Enterprise value 217.24M
Trailing P/E N/A
Forward P/E 2.85
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.27
Price/book (mrq)N/A
Enterprise value/revenue 23.71
Enterprise value/EBITDA -4.18

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 3-61.32%
S&P500 52-week change 322.64%
52-week high 340.60
52-week low 34.00
50-day moving average 38.50
200-day moving average 312.05

Share statistics

Avg vol (3-month) 3642.11k
Avg vol (10-day) 3265.83k
Shares outstanding 523.3M
Implied shares outstanding 623.33M
Float 85.87M
% held by insiders 138.85%
% held by institutions 122.74%
Shares short (15 Apr 2024) 41.13M
Short ratio (15 Apr 2024) 40.68
Short % of float (15 Apr 2024) 45.78%
Short % of shares outstanding (15 Apr 2024) 44.85%
Shares short (prior month 15 Mar 2024) 4785.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Mar 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 314 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-70.76%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -47.7M
Net income avi to common (ttm)-51.5M
Diluted EPS (ttm)-4.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.36M
Total cash per share (mrq)0.8
Total debt (mrq)36.55M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.44
Book value per share (mrq)-1.87

Cash flow statement

Operating cash flow (ttm)-47.1M
Levered free cash flow (ttm)-30.69M